DHODH and neuroblastoma: To investigate how Regorafenib-mediated DHODH inhibition affects neuroblastoma cells, we conducted TMT-based quantitative proteomics analysis using TMT labeling and LC/MS-MS (Fig. 5A and supplemental Fig. S4).